Vertex Pharmaceuticals (VRTX) is the second stock to buy for the Nasdaq 100 correction. The biotech stock offers stability ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

Bank of America upped its price target for Vertex Pharmaceuticals from $555 to $567, signaling growing confidence in the ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

Analysts' ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) over the last quarter vary from bullish to bearish, as provided by 17 analysts. The table below summarizes their recent ratings ...

Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...

Vertex’s effort to provide fertility support services to those on government insurance programs who want to take the ...

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to trigger sufficient levels of insulin production in a phase 1/2 trial.

MONTGOMERY, Ala. (WSFA) - Halfway through the 2025 Alabama legislative session, state lawmakers are bringing gambling back to the table. State Senator Greg Albritton filed legislation Tuesday that ...

Grab your camp chairs and prep the charcuterie, because Honda is bringing back the built-in picnic table. The 2026 Honda Passport revives an idea first seen in the original CR-V with a table that ...

Its online service includes Web Trade VIA Vertex Aero. Its online platform for investors includes back-office client, mutual fund, online trade, commodity back office, equity back office and ...